Integrase inhibitors: first clear success in human trial.
Ten-day trial showed clear reduction of viral load in volunteers.
James
John S
JS
D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009930:Organic Chemicals / Q000627:therapeutic use*; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D019562:Viral Load
D019428:HIV Integrase Inhibitors; D009930:Organic Chemicals; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium